146 related articles for article (PubMed ID: 11062974)
1. [Anti-angiogenesis drugs as a potential approach in cancer therapy].
Sela B
Harefuah; 2000 Oct; 139(7-8):283-9. PubMed ID: 11062974
[No Abstract] [Full Text] [Related]
2. Angiogenesis inhibitors: an upcoming therapy for cancer and wet age-related macular degeneration.
Sweeney K
Drug Discov Today; 2005 Oct; 10(20):1346-8. PubMed ID: 16253870
[No Abstract] [Full Text] [Related]
3. Antiangiogenic therapy for cancer: an update.
Shojaei F; Ferrara N
Cancer J; 2007; 13(6):345-8. PubMed ID: 18032969
[TBL] [Abstract][Full Text] [Related]
4. [Anti-angiogenic therapeutic strategies and inhibition of tumor growth].
Bachelot T
Ann Pathol; 1999; 19(5 Suppl):S74-5. PubMed ID: 10599459
[No Abstract] [Full Text] [Related]
5. American Association for Cancer Research 98th Annual Meeting. Angiogenesis and anti-angiogenesis in cancer.
Duda DG
IDrugs; 2007 Jun; 10(6):366-9. PubMed ID: 17641996
[No Abstract] [Full Text] [Related]
6. Microtubule-targeting agents in angiogenesis: where do we stand?
Pasquier E; Honoré S; Braguer D
Drug Resist Updat; 2006; 9(1-2):74-86. PubMed ID: 16714139
[TBL] [Abstract][Full Text] [Related]
7. [Targeting angiogenesis in oncology].
Fayette J; Soria JC; Armand JP
Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis: What can it offer for future medicine?
Cao Y
Exp Cell Res; 2010 May; 316(8):1304-8. PubMed ID: 20206162
[TBL] [Abstract][Full Text] [Related]
9. [Angiogenesis and antiangiogenic cancer therapy].
Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
Folkman J
Exp Cell Res; 2006 Mar; 312(5):594-607. PubMed ID: 16376330
[TBL] [Abstract][Full Text] [Related]
11. Advances in the use of angiogenesis inhibitors in cancer.
Pinedo HM
Cancer J; 2001; 7 Suppl 3():S107-8. PubMed ID: 11779080
[No Abstract] [Full Text] [Related]
12. [Angiogenesis in cancer].
Pozner RG; Negrotto S; Schattner M
Medicina (B Aires); 2002; 62(6):604-6. PubMed ID: 12532700
[No Abstract] [Full Text] [Related]
13. Angiogenesis in malignancy.
Cao Y
Semin Cancer Biol; 2009 Oct; 19(5):277-8. PubMed ID: 19945648
[No Abstract] [Full Text] [Related]
14. Cancer immunotherapy of targeting angiogenesis.
Hou J; Tian L; Wei Y
Cell Mol Immunol; 2004 Jun; 1(3):161-6. PubMed ID: 16219162
[TBL] [Abstract][Full Text] [Related]
15. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.
Roukos DH; Tzakos A; Zografos G
Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000
[No Abstract] [Full Text] [Related]
16. From the Guest Editor: Monoclonal antibodies have emerged as versatile and useful cancer therapeutics.
Weiner LM
Cancer J; 2008; 14(3):147-8. PubMed ID: 18536553
[No Abstract] [Full Text] [Related]
17. Selective targeting of the tumour vasculature.
Chan LS; Daruwalla J; Christophi C
ANZ J Surg; 2008 Nov; 78(11):955-67. PubMed ID: 18959693
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis: from plants to blood vessels.
Fan TP; Yeh JC; Leung KW; Yue PY; Wong RN
Trends Pharmacol Sci; 2006 Jun; 27(6):297-309. PubMed ID: 16697473
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathways for cancer angioprevention.
Albini A; Noonan DM; Ferrari N
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4320-5. PubMed ID: 17671111
[TBL] [Abstract][Full Text] [Related]
20. A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy.
D'Onofrio A; Gandolfi A
Math Med Biol; 2009 Mar; 26(1):63-95. PubMed ID: 19033598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
